Clinical Trials Directory

Trials / Unknown

UnknownNCT04463901

Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C

Intraoperative Mitomycin C Combined With Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium: a Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this randomized clinical trial is to compare the efficacy and safety of intraoperative mitomycin C(MMC) combined with limbal conjunctival autograft(LCAG) or conjunctival autograft(CAG) for recurrent pterygium surgery. The investigators will also evaluate particular risk factors related to pterygium recurrence

Detailed description

Intraoperative mitomycin C after pterygium excision is widely used to prevent recurrce of recurrent pterygium. Conjunctival autograft with or without limbal tissue used to cover the bare sclera will efficiently reduce postoperative longstanding epithelial defect. Patients with recurrent pterygium will be randomly assigned to undertake pterygium excision followed by intraoperative mitomycin C with conjunctival autograft or limbal conjunctival autograft .The patients will be followed at least 12 months. Corneal recurrence is considered as a fibrovascular ingrowth beyond the limbus with conjunctival drag in the area of previous pterygium excision.

Conditions

Interventions

TypeNameDescription
PROCEDUREPterygium excisionPartial conjunctiva and anterior tenon's membrane underneath will be removed after the excision of pterygium tissue.
PROCEDUREIntraoperative mitomycin CIntraoperative mitomycin C (0.02%) will be applied for 5 minutes after pterygium excision.
PROCEDUREConjunctival autograftA conjunctival autograft will be applied to cover the conjunctival defect after pterygium excision.
PROCEDURELimbal conjunctival autograftA limbal conjunctival autograft will be applied to cover the conjunctival defect after pterygium excision.

Timeline

Start date
2016-02-01
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2020-07-09
Last updated
2020-07-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04463901. Inclusion in this directory is not an endorsement.